{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:43:36Z","timestamp":1770975816085,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":332,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.rmcr.2025.102340","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:28:22Z","timestamp":1764635302000},"page":"102340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report"],"prefix":"10.1016","volume":"58","author":[{"given":"Yara","family":"Salameh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.rmcr.2025.102340_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2025.102340_bib2","series-title":"Cystic Fibrosis and Liver Disease. Statpearls. Treasure Island (FL): Statpearls Publishing Copyright \u00a9 2024","author":"Betapudi","year":"2024"},{"key":"10.1016\/j.rmcr.2025.102340_bib3","series-title":"Cystic Fibrosis. Statpearls","author":"Yu","year":"2024"},{"issue":"3","key":"10.1016\/j.rmcr.2025.102340_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2020.07.014","article-title":"Biliary disease and cholecystectomy after initiation of elexacaftor\/ivacaftor\/tezacaftor in adults with cystic fibrosis","volume":"20","author":"Safirstein","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102340_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000010","article-title":"Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis","volume":"7","author":"Levitte","year":"2023","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.rmcr.2025.102340_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.rmcr.2025.102340_bib7","series-title":"Statpearls","article-title":"Gilbert syndrome","author":"Grant","year":"2024"},{"issue":"11","key":"10.1016\/j.rmcr.2025.102340_bib8","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4254\/wjh.v13.i11.1727","article-title":"Cystic fibrosis associated liver disease in children","volume":"13","author":"Valamparampil","year":"2021","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.rmcr.2025.102340_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ppul.26831","article-title":"Gilbert\u2019s syndrome leads to elevated bilirubin after initiation of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis","volume":"59","author":"Patel","year":"2024","journal-title":"Pediatr. Pulmonol."},{"issue":"6","key":"10.1016\/j.rmcr.2025.102340_bib10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jcf.2023.06.013","article-title":"Hyperbilirubinemia and gilbert's syndrome in cystic fibrosis patients treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Terlizzi","year":"2023","journal-title":"J. Cyst. Fibros.: official journal of the European Cystic Fibrosis Society"},{"issue":"4","key":"10.1016\/j.rmcr.2025.102340_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.21105","article-title":"Coinheritance of Gilbert syndrome\u2013associated UGT1A1 mutation increases gallstone risk in cystic fibrosis","volume":"43","author":"Wasmuth","year":"2006","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.rmcr.2025.102340_bib12","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/mp4001348","article-title":"Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia","volume":"10","author":"Chang","year":"2013","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102340_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425255.1.3.429","article-title":"Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination","volume":"1","author":"Smith","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:40:47Z","timestamp":1770972047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125001765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":13,"alternative-id":["S2213007125001765"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102340","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking hyperbilirubinemia: Gilbert syndrome in children with cystic fibrosis, a case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102340"}}